Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelatin tannate in children with acute gastroenteritis
NCT02280759Phase 1Completed
- Sponsor
- Medical University of Warsaw
- Start
- Nov 2014
- Primary completion
- Jun 2017
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of gelatin tannate in acute gastroenteritis, sponsored by Medical University of Warsaw. Primary endpoint: Duration of diarrhea at 7 days. Started Nov 2014; status: completed.
02
Drugs
gelatin tannate
03
Conditions
acute gastroenteritis
Beyond the preview
Go deeper on NCT02280759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280759.